AAAAAA
Results: 1-25/64
Authors:
BUNN PA
KELLY K
Citation: Pa. Bunn et K. Kelly, NEW CHEMOTHERAPEUTIC-AGENTS PROLONG SURVIVAL AND IMPROVE QUALITY-OF-LIFE IN NONSMALL CELL LUNG-CANCER - A REVIEW OF THE LITERATURE AND FUTURE-DIRECTIONS, Clinical cancer research, 4(5), 1998, pp. 1087-1100
Authors:
BUNN PA
KELLY K
Citation: Pa. Bunn et K. Kelly, NEW CHEMOTHERAPEUTIC-AGENTS PROLONG SURVIVAL AND IMPROVE QUALITY-OF-LIFE IN NONSMALL CELL LUNG-CANCER - A REVIEW OF THE LITERATURE AND FUTURE-DIRECTIONS, Clinical cancer research, 4(5), 1998, pp. 1087-1100
Authors:
BUNN PA
HELFRICH BA
BRENNER DG
CHAN DC
DYKES DJ
COHEN AJ
MILLER YE
Citation: Pa. Bunn et al., EFFECTS OF RECOMBINANT NEUTRAL ENDOPEPTIDASE (EC 3.4.24.11) ON THE GROWTH OF LUNG-CANCER CELL-LINES IN-VITRO AND IN-VIVO, Clinical cancer research, 4(11), 1998, pp. 2849-2858
Authors:
KELLY K
HAZUKA M
PAN ZZ
MURPHY J
CASKEY J
LEONARD C
BUNN PA
Citation: K. Kelly et al., A PHASE-I STUDY OF DAILY CARBOPLATIN AND SIMULTANEOUS ACCELERATED, HYPERFRACTIONATED CHEST IRRADIATION IN PATIENTS WITH REGIONALLY INOPERABLE NONSMALL CELL LUNG-CANCER, International journal of radiation oncology, biology, physics, 40(3), 1998, pp. 559-567
Authors:
KELLY K
BUNN PA
Citation: K. Kelly et Pa. Bunn, IS IT TIME TO REEVALUATE OUR APPROACH TO THE TREATMENT OF BRAIN METASTASES IN PATIENTS WITH NONSMALL CELL LUNG-CANCER, Lung cancer, 20(2), 1998, pp. 85-91
Authors:
BUNN PA
LECHEVALIER T
Citation: Pa. Bunn et T. Lechevalier, LUNG-CANCER RESEARCH - NEW COMBINATIONS AND THE EMERGING ROLE OF GEMCITABINE, Seminars in oncology, 25(4), 1998, pp. 1-1
Authors:
BUNN PA
VOKES EE
LANGER CJ
SCHILLER JH
Citation: Pa. Bunn et al., AN UPDATE ON NORTH-AMERICAN RANDOMIZED STUDIES IN NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(4), 1998, pp. 2-10
Authors:
BUNN PA
Citation: Pa. Bunn, TRIPLET CHEMOTHERAPY COMBINATIONS WITH NEW AGENTS - IS THERE A RATIONALE, Seminars in oncology, 25(4), 1998, pp. 55-61
Authors:
BUNN PA
Citation: Pa. Bunn, CANCER AND ACQUIRED-IMMUNODEFICIENCY-SYNDROME WASTING SYNDROMES - CURRENT AND FUTURE THERAPIES, Seminars in oncology, 25(2), 1998, pp. 1-3
Authors:
AHNEN DJ
FEIGL P
QUAN G
FENOGLIOPREISER C
LOVATO LC
BUNN PA
STEMMERMAN G
WELLS JD
MACDONALD JS
MEYSKENS FL
Citation: Dj. Ahnen et al., KI-RAS MUTATION AND P53 OVEREXPRESSION PREDICT THE CLINICAL BEHAVIOR OF COLORECTAL-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Cancer research, 58(6), 1998, pp. 1149-1158
Authors:
BEEKMAN A
HELFRICH B
BUNN PA
HEASLEY LE
Citation: A. Beekman et al., EXPRESSION OF CATALYTICALLY INACTIVE PHOSPHOLIPASE C-BETA DISRUPTS PHOSPHOLIPASE C-BETA AND MITOGEN-ACTIVATED PROTEIN-KINASE SIGNALING AND INHIBITS SMALL-CELL LUNG-CANCER GROWTH, Cancer research, 58(5), 1998, pp. 910-913
Authors:
KELLY K
PAN ZX
MURPHY J
HUFFMAN DH
BUNN PA
Citation: K. Kelly et al., A PHASE-I TRIAL OF PACLITAXEL PLUS CARBOPLATIN IN UNTREATED PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Clinical cancer research, 3(7), 1997, pp. 1117-1123
Authors:
PISTERS KMW
KRIS MG
BUNN PA
JOHNSON DH
RUCKDESCHEL JC
CROWLEY JJ
GINSBERG RJ
Citation: Kmw. Pisters et al., INDUCTION PACLITAXEL CARBOPLATIN IN EARLY-STAGE NONSMALL CELL LUNG-CANCER/, Seminars in oncology, 24(4), 1997, pp. 41-44
Authors:
BUNN PA
KELLY K
Citation: Pa. Bunn et K. Kelly, A PHASE-I STUDY OF CISPLATIN, ETOPOSIDE, AND PACLITAXEL IN SMALL-CELLLUNG-CANCER, Seminars in oncology, 24(4), 1997, pp. 144-148
Authors:
BUNN PA
Citation: Pa. Bunn, DEFINING THE ROLE OF PACLITAXEL IN LUNG-CANCER - SUMMARY OF RECENT STUDIES AND IMPLICATIONS FOR FUTURE-DIRECTIONS, Seminars in oncology, 24(4), 1997, pp. 153-162
Authors:
BUNN PA
Citation: Pa. Bunn, THE EMERGING ROLE OF GEMCITABINE IN LUNG-CANCER, Seminars in oncology, 24(3), 1997, pp. 81-81
Authors:
BUNN PA
KELLY K
Citation: Pa. Bunn et K. Kelly, SYSTEMIC INVESTIGATIONAL THERAPIES AS ADJUVANTS TO SURGERY IN PATIENTS WITH OPERABLE LUNG-CANCER, Seminars in oncology, 24(3), 1997, pp. 846-852
Authors:
DINARELLO CA
BUNN PA
Citation: Ca. Dinarello et Pa. Bunn, FEVER, Seminars in oncology, 24(3), 1997, pp. 288-298
Authors:
BUNN PA
Citation: Pa. Bunn, THE EMERGING ROLE OF GEMCITABINE IN LUNG-CANCER .1., Seminars in oncology, 24(2), 1997, pp. 1-1
Authors:
BUNN PA
CARNEY DN
Citation: Pa. Bunn et Dn. Carney, OVERVIEW OF CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER, Seminars in oncology, 24(2), 1997, pp. 69-74
Authors:
COHEN AJ
SKIDGEL RA
GILMAN LB
BLACK JK
BUNN PA
HELFRICH B
FRANKLIN WA
MILLER YE
Citation: Aj. Cohen et al., CARBOXYPEPTIDASE-M - VARIABLE EXPRESSION IN NORMAL HUMAN LUNG AND INACTIVATION IN LUNG-CANCER, Chest, 111(6), 1997, pp. 149-149
Authors:
KIRPOTIN D
HELFRICH B
HELM K
CHAN D
BUNN PA
Citation: D. Kirpotin et al., CYTOFLUOROMETRY STUDY OF ENDOCYTOSIS AND CELLULAR-DISTRIBUTION OF FLUORESCEIN-LABELED SUBSTRATES, Molecular biology of the cell, 7, 1996, pp. 1539-1539
Authors:
FRANKLIN WA
FOLKVORD JM
VARELLAGARCIA M
KENNEDY T
PROUDFOOT S
COOK R
DEMPSEY EC
HELM K
BUNN PA
MILLER YE
Citation: Wa. Franklin et al., EXPANSION OF BRONCHIAL EPITHELIAL-CELL POPULATIONS BY IN-VITRO CULTURE OF EXPLANTS FROM DYSPLASTIC AND HISTOLOGICALLY NORMAL SITES, American journal of respiratory cell and molecular biology, 15(3), 1996, pp. 297-304
Authors:
BUNN PA
FOSS FM
Citation: Pa. Bunn et Fm. Foss, T-CELL LYMPHOMA CELL-LINES (HUT102 AND HUT78) ESTABLISHED AT THE NATIONAL-CANCER-INSTITUTE - HISTORY AND IMPORTANCE TO UNDERSTANDING THE BIOLOGY, CLINICAL-FEATURES, AND THERAPY OF CUTANEOUS T-CELL LYMPHOMAS (CTCL) AND ADULT T-CELL LEUKEMIA-LYMPHOMAS (ATLL), Journal of cellular biochemistry, 1996, pp. 12-23
Authors:
PHELPS RM
JOHNSON BE
IHDE DC
GAZDAR AF
CARBONE DP
LINNOILA PRMRI
MATTHEWS MJ
BUNN PA
CARNEY D
MINNA JD
MULSHINE JL
Citation: Rm. Phelps et al., NCI-NAVY MEDICAL ONCOLOGY BRANCH CELL-LINE DATA-BASE, Journal of cellular biochemistry, 1996, pp. 32-91